| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 6914-71-2 | 1,1-環(huán)丙烷二甲酸二甲酯 | 1,1-Cyclopropanedicarboxylic acid dimethyl ester; 1,1-Cyclopropanedicarboxylicacid, dimethyl ester (7CI,8CI,9CI); Dimethyl 1,1-cyclopropanedicarboxylate |  | C7H10O4 | 詳情 | 供應商 |
| 6914-79-0 | 1-氰基-1-環(huán)丙烷羧酸; 1-氰基環(huán)丙烷-1-羧酸 | 1-Cyano-1-cyclopropanecarboxylic acid |  | C5H5NO2 | 詳情 | 供應商 |
| 17994-25-1 | 1-羥基環(huán)丙烷羧酸; 1-羥基-1-環(huán)丙烷羧酸 | 1-Hydroxy-1-cyclopropanecarboxylic acid; 1-Hydroxy-1-cyclopropanecarboxylicacid; 1-Hydroxycyclopropanecarboxylic acid |  | C4H6O3 | 詳情 | 供應商 |
| 39590-81-3 | 1,1-環(huán)丙烷二甲醇; 1,1-環(huán)丙二甲醇 | 1,1-Bis(hydroxymethyl)cyclopropane; Cyclopropanedimethanol |  | C5H10O2 | 詳情 | 供應商 |
| 939-87-7 | 反-2-苯基-1-環(huán)丙甲酰氯; 反式-2-苯基-1-環(huán)丙烷羰基; | Cyclopropanecarbonylchloride, 2-phenyl-, (1R,2R)-rel-; Cyclopropanecarbonylchloride, 2-phenyl-, trans- (8CI); (?à)-trans-2-Phenylcyclopropanecarboxylic acid chloride; NSC 80667; trans-2-Phenyl-1-cyclopropanecarbonyl chloride; trans-2-Phenylcyclopropane-1-carboxylic acid chloride; trans-2-Phenylcyclopropanecarbonyl chloride |  | C10H9ClO | 詳情 | 供應商 |
| 935-44-4 | 1-苯基-1-環(huán)丙烷腈; 1-苯基環(huán)丙基甲腈 | Cyclopropanecarbonitrile,1-phenyl-; 1-Cyano-1-phenylcyclopropane; 1-Phenyl-1-cyclopropanecarbonitrile; 1-Phenylcyclopropanecarbonitrile; 1-Phenylcyclopropanenitrile; 1-Phenylcyclopropyl cyanide; NSC 126430 |  | C10H9N | 詳情 | 供應商 |
| 80866-81-5 | 1-(4-氯苯基)-1-環(huán)丙烷甲醇 | Cyclopropanemethanol,1-(4-chlorophenyl)-; 1-(4-Chlorophenyl)-1-cyclopropanemethanol |  | C10H11ClO | 詳情 | 供應商 |
| 89729-09-9 | 1,1-環(huán)丙烷二甲醇亞磺酸酯 | 5,7-Dioxa-6-thiaspiro[2.5]octane,6-oxide; 1,1-Cyclopropanedimethanol,cyclic sulfite (7CI) |  | C5H8O3S | 詳情 | 供應商 |
| 849217-68-1 | CABOZANTINIB; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-環(huán)丙烷二甲酰胺 | N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; Cabozantinib; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL184; Cabozantinib(XL184) |  | C28H24FN3O5 | 詳情 | 供應商 |
| 1140909-48-3 | N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-環(huán)丙烷二甲酰胺 (S)-蘋果酸鹽; CABOZANTINIB (S)-蘋果酸鹽; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-環(huán)丙烷二甲酰胺 (S)-蘋果酸鹽; CABOZANTINIB MALATE; 卡博替尼蘋果酸鹽; 蘋果酸卡博替尼; L-蘋果酸卡博替尼 | (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); Cabozantinib (S)-malate; Cabozantinib L-Malate Salt; N-[4-[(6,7-DiMethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxaMide (2S)-; Cabozantinib (S)-Malate(XL-184); Cabozantinib L-Malate |  | C32H30FN3O10 | 詳情 | 供應商 |
| 1225278-16-9 | DCC-2618; N-[2,5-二氟-4-[[2-(1-甲基-1H-吡唑-4-基)-4-吡啶基]氧基]苯基]-N'-苯基-1,1-環(huán)丙烷二甲酰胺 | DCC-2618; DCC-2618; N-[2,5-Difluoro-4-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]phenyl]-N'-phenyl-1,1-cyclopropanedicarboxamide | 無 | C26H21F2N5O3 | 詳情 | 供應商 |